Alimera Sciences (ALIM) director Sawhney received 2,252 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Roger Sawhney (director at Alimera Sciences Inc., ALIM) reported that they received 2,252 Stock Option (Right to Buy) on Feb 25, 2023.
- Reporting person
- Sawhney Roger
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 25, 2023 | Grant or award (A) | Stock Option (Right to Buy)On 2,252 Common Stock1, 2 | +2,252 | - | - | 2,252 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 2,252 direct
Footnotes from the filing
- 1. The closing price for the Issuer's common stock on the Nasdaq Global Market on February 27, 2023, the first trading day after the grant of the options.
- 2. Options vest monthly and become exercisable in equal monthly installments beginning on March 12, 2023, and ending on July 12, 2023, with the final installment adjusted as necessary to avoid any fractional shares in any installment.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Sawhney report in this ALIM Form 4?
Roger Sawhney (director at Alimera Sciences Inc., ALIM) reported that they received 2,252 Stock Option (Right to Buy) on Feb 25, 2023.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for ALIM
Earlier insider filings at ALIM
- Feb 6, 2023SEC Form 4: Ashman Philip covered exercise/tax liability with 2,889 shares, decreasing direct ownership by 9% to 30,315 units (tax withholding)
- Jan 10, 2023SEC Form 4: Skibsted Russell was granted 17,500 shares
- Jan 7, 2023SEC Form 4 filed by Parsons Erin
- Jan 6, 2023SEC Form 4 filed by Halak Brian K
- Jan 6, 2023SEC Form 4 filed by Snisarenko John
Quantisnow market dataNASDAQ
ALIM
Alimera Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2010
Get push alerts for ALIM
Full ALIM profile on Quantisnow Follow ALIM and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time